Early combination therapy with SGLT2i and GLP-1 RA or dual GIP/GLP-1 RA in type 2 diabetes. Vale C, Lourenco IM, Jordan G, Golovaty I, et al. Diabetes Obes Metab 2024 Nov 27. doi: 10.1111/dom.16077.

Read + Share

Amedeo Smart

Independent Medical Education

Vale C, Lourenco IM, Jordan G, Golovaty I, et al. Early combination therapy with SGLT2i and GLP-1 RA or dual GIP/GLP-1 RA in type 2 diabetes. Diabetes Obes Metab 2024 Nov 27. doi: 10.1111/dom.16077.
PMID: 39604324